Meeting
2020 Genitourinary Cancers Symposium
Association of black race with improved outcomes following definitive radiotherapy with androgen deprivation therapy for high-risk prostate cancer: A meta-analysis of eight randomized trials.
Authors
Amar Upadhyaya Kishan
Department of Radiation Oncology, University of California, Los Angeles, CA
Amar Upadhyaya Kishan , Tahmineh Romero , Matthew Rettig , Isla Garraway , Mack Roach III, Thomas Michael Pisansky , Jeff M. Michalski , W. Robert Lee , Christopher U. Jones , Seth A. Rosenthal , Felix Y Feng , Paul Christopher Boutros , Nicholas George Nickols , Brandon Arvin Virgil Mahal , Robert Timothy Dess , Phuoc T. Tran , Michael L. Steinberg , David Elashoff , Howard M. Sandler , Daniel Eidelberg Spratt
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 327)
Abstract #
327
Poster Bd #
M11
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Basal-luminal subtyping of localized high-risk prostate cancer and benefit of adding docetaxel to definitive radiotherapy with androgen suppression in the NRG Oncology/RTOG 0521 phase III trial.
First Author: Ryan Phillips
Poster
2022 ASCO Genitourinary Cancers Symposium
Local failure, distant metastasis, and survival after definitive radiotherapy for intermediate- and high-risk prostate cancer: An individual patient-level meta-analysis of 18 randomized trials.
First Author: Ting Martin Ma
Poster
2018 Genitourinary Cancers Symposium
The importance of the need for better systemic therapy in the definitive treatment of high-risk prostate cancer regardless of whether the initial treatment modality was external beam radiation, I-125 brachytherapy, or radical prostatectomy.
First Author: Jay P. Ciezki
Poster
2024 ASCO Genitourinary Cancers Symposium
Update from the PSMA-dRT trial: A randomized phase III trial of PSMA-PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer.
First Author: John Nikitas